Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K.
Go back to Pasithea Therapeutics Adds Esketamine Nasal Spray to its Clinic Offerings in the U.K.| (NASDAQ: KTTA) | Delayed: 7.24 +0.29 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.95 | 52 Week High | $ | |||
| Open | $7.24 | 52 Week Low | $ | |||
| Day High | $7.24 | P/E | N/A | |||
| Day Low | $7.24 | EPS | $ | |||
| Volume | 328 | |||||
| (NASDAQ: KTTAW) | Delayed: 0.01 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $ | |||
| Open | $0.01 | 52 Week Low | $ | |||
| Day High | $0.01 | P/E | N/A | |||
| Day Low | $0.01 | EPS | $ | |||
| Volume | 3,285 | |||||
